A new study from the Mercatus Center, a libertarian policy center at George Mason University, projects that progressive Democrats' "Medicare for All" plan would cost the government $32.6 trillion over 10 years.
Why it matters: The study concludes that doubling all federal individual and corporate income taxes would not be enough to cover the added costs of the plan.
A promising new drug called BAN2401 generated a lot of excitement after a clinical trial found it slowed the progression of Alzheimer’s by 30%, but recent revelations have left investors and doctors with more questions than answers, reports Bloomberg.
The bottom line: Whenever you hear about a promising new Alzheimer’s treatment, make a mental note to check back in a few months — or even a few days — to see if it’s still worth your attention.
